
Metastatic Bladder Cancer — Rapid Case Review Issue 3
Oncology Today with Dr Neil Love
00:00
How long to continue EV and pembrolizumab
Milowsky cites median cycles from EV302 and suggests up to 24 months for immunotherapy, tailoring EV to toxicity.
Play episode from 10:30
Transcript


